Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Odense University Hospital, Odense, Denmark
Cleveland Clinic, Cleveland, Ohio, United States
Hvidovre University Hospital, Copenhagen, Hvidovre, Denmark
University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy
University of Auckland, Auckland, New Zealand
Manukau Surgery Centre-Middlemore Hospital, Auckland, New Zealand
Cleveland Clinic/Hillcrest Hospital, Mayfield Heights, Ohio, United States
University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
William Beaumont Hospital, Royal Oak, Michigan, United States
William Beaumont Hospitals, Troy, Michigan, United States
College of Medicine of Botucatu, Botucatu, São Paulo, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.